HIGHLIGHTS
- who: Angel A. Gu00f3mez-Gallegos from the Instituto de Fisiologu00eda Celular IMPI have published the research work: CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence, in the Journal: (JOURNAL)
- what: The authors aim to ensure that cells with this phenotype have stemness and self-renewal capabilities. To evaluating the presence of CSCs with an extended phenotype in samples from patients with primary GC, which could enable more specific identification, the authors aimed to determine the relationship of these highly tumorigenic cancer cells with prognosis and metastasis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.